✦ LIBER ✦

Insulin-like growth factors and prostate cancer

✍ Scribed by Bob Djavan; Matthias Waldert; Christian Seitz; Michael Marberger

Publisher: Springer-Verlag
Year: 2001
Tongue: English
Weight: 140 KB
Volume: 19
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s003450100220

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum insulin-like growth factors and mo

Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer

✍ Mari-Anne Rowlands; Jeff M. P. Holly; Freddie Hamdy; Joshua Phillips; Louise Goo 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 185 KB

Circulating insulin-like growth factor p

Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis

✍ Mari-Anne Rowlands; David Gunnell; Ross Harris; Lars J. Vatten; Jeff M.P. Holly; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 556 KB

## Abstract Insulin‐like growth factors (IGF‐I, IGF‐II) and their binding proteins (IGFBP‐1–6) play a key role in cell proliferation, differentiation and apoptosis, suggesting possible involvement in carcinogenesis. Several epidemiological studies show associations of IGFs with prostate cancer. We

Screen-detected prostate cancer and the

Screen-detected prostate cancer and the insulin-like growth factor axis: Results of a population-based case-control study

✍ Steven E. Oliver; David Gunnell; Jenny Donovan; Tim J. Peters; Raj Persad; David 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 86 KB 👁 1 views

## Abstract Higher circulating levels of IGF‐I have been associated with increased risk of prostate and some other cancers. Most research on prostate cancer has been based on men with symptoms or identified following treatment of benign disease. However, increasing numbers of cancer cases are now d

Plasma insulin-like growth factor-1 and

Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

✍ Elizabeth A. Platz; Michael N. Pollak; Michael F. Leitzmann; Meir J. Stampfer; W 📂 Article 📅 2005 🏛 Springer Netherlands 🌐 English ⚖ 186 KB

Apigenin suppresses insulin-like growth

Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study

✍ Sanjeev Shukla; Sanjay Gupta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

## Abstract Deregulation of insulin‐like growth factor (IGF)‐I/IGF‐IR signaling has been implicated in the development and progression of prostate cancer. Agents that can suppress the mitogenic activity of the IGF/IGF‐IR growth axis may be of preventive or therapeutic value. We have previously demo

Sex hormone-induced prostatic carcinogen

Sex hormone-induced prostatic carcinogenesis in the Noble rat: The role of insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) in the development of prostate cancer

✍ Wang, Y.Z.; Wong, Y.C. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 906 KB

## Background: Despite extensive effort, the mechanisms of prostate carcinogenesis are still unknown. we report on a modified method which enabled us to induce a high incidence of prostate carcinogenesis in the noble rat and examined the role of insulin-like growth factor-1 (igf-1) and vascular end